Michael Wiggins De Oliveira, author at Seeking Alpha, discusses health supplement retailer GNC as his "Idea of the Month."
He notes that even though the company is in debt by more than $1 billion, it's still a buy for him because of the measures the company is taking to wipe out the debt, including the $200 million in annual free cash flow.
Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
You might already be planning your Thanksgiving menu as the holiday approaches. Some retailers are offering deals that could help your pockets as you budget for those large family gatherings.
